Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes

Fig. 5

XOI-based ULT effects on FA metabolism. A PLS-DA separation between patients with different pattern of FA levels after ULT therapy: 17 patients did not decrease FA [1], and 17 patients significantly decreased FA [2]. B The variables important in projection (VIP) in discriminate both groups, where a VIP score ≥ 1 was considered as important. C Characteristics of patients in both clusters. Continuous variables were expressed as mean ± standard deviation (SD) and categorical variables as number (N) and percentage

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us